Gemfibrozil and Otitis - a phase IV clinical study of FDA data

Summary:

Otitis is reported as a side effect among people who take Gemfibrozil (gemfibrozil), especially for people who are female, 50-59 old, also take Singulair, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Otitis when taking Gemfibrozil. It is created by eHealthMe based on reports of 17,763 people who have side effects when taking Gemfibrozil from the FDA, and is updated regularly.

What is Gemfibrozil?

Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.

What is Otitis?

Otitis (ear infection) is found to be associated with 1,420 drugs and 1,831 conditions by eHealthMe. Check the latest studies of Otitis.

On Jul, 19, 2026

17,763 people reported to have side effects when taking Gemfibrozil.
Among them, 28 people (0.16%) have Otitis.

Among these 28 people:

What is the gender of people who have Otitis when taking Gemfibrozil? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Otitis when taking Gemfibrozil? *

What are other drugs people take besides Gemfibrozil? *

Singulair: 14 people, 50.00%
Epinephrine: 10 people, 35.71%
Acetaminophen: 10 people, 35.71%
Topamax: 6 people, 21.43%
Lidocaine: 6 people, 21.43%
Zofran: 5 people, 17.86%
Lipitor: 5 people, 17.86%
Ibuprofen: 5 people, 17.86%
Fluticasone Propionate: 5 people, 17.86%
Metformin: 4 people, 14.29%

What are other side effects people have besides Otitis? *

Sinusitis (inflammation of sinus): 13 people, 46.43%
Nausea (feeling of having an urge to vomit): 7 people, 25.00%
Arthritis Infective (purulent invasion of a joint by an infectious agent which produces arthritis): 6 people, 21.43%
Fatigue (feeling of tiredness): 5 people, 17.86%
Headache (pain in head): 5 people, 17.86%
Application Site Pruritus (application site severe itching of the skin): 4 people, 14.29%
Gastric Infection (infection of stomach): 4 people, 14.29%
High Blood Pressure: 4 people, 14.29%
Cellulitis (infection under the skin): 4 people, 14.29%
Sedation: 3 people, 10.71%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 13 people, 46.43%
Conductive Deafness (deafness due to a problem in conducting sound waves): 8 people, 28.57%
Brain Neoplasm Benign (non-cancerous tumour of brain): 3 people, 10.71%
Astrocytoma, Low Grade (low grade tumour of the brain that originate in a particular kind of glial-cells): 3 people, 10.71%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 7.14%
High Blood Pressure: 2 people, 7.14%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 3.57%
Ovarian Cancer (cancer of ovary): 1 person, 3.57%
Nausea (feeling of having an urge to vomit): 1 person, 3.57%
Multiple Myeloma (cancer of the plasma cells): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Gemfibrozil and have Otitis?

- Check whether Otitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemfibrozil:

Gemfibrozil (18,213 reports)

Otitis treatments and more:

Otitis (36,446 reports)

Browse all side effects of Gemfibrozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Otitis:

Otitis (1,420 drugs)

Browse all the conditions that are associated with Otitis:

Otitis (1,831 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gemfibrozil (the active ingredients of Gemfibrozil) and Gemfibrozil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.